Tag:
Vancocin
Latest Headlines
Latest Headlines
ViroPharma's FDA challenge dismissed by federal court
ViroPharma lost a U.S. court bid to delay generic competition for its key product, Vancocin. The company had challenged FDA's choice to allow generics makers to launch their versions of the infection
